Search
for
Sort by
Research 541–570 of 1000+
- New therapies for alopecia areata
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- Scaffolds for epithelial and hair follicle regeneration
- American Society for Laser Medicine and Surgery - 2018 Late-Breaking Abstracts
- Current systemic treatment strategies for hidradenitis suppurativa
- Cap Wearing and Quality of Life in Patients with Androgenic Alopecia amongst Indian Population
- Janus Kinase inhibitors in dermatology: a review
- Construction strategies of skin organoids: A review
- Phytochemical and Therapeutic Evaluation of Curcumin and Piperine in Alopecia
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Clinical Efficacy of Platelet-Rich Plasma in the Management of Androgenetic Alopecia: A Prospective Comparative Study
- Herbal Approaches for the Management of Premature Hair Greying: Mechanisms, Phytoconstituents and Delivery Strategies
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Reversing Time with Peptides: Mechanisms, Classifications, and Innovations in Anti-aging Interventions
- Effectiveness of Platelet-Rich Plasma Vs Growth Factor Concentrate in Androgenic Alopecia and Telogen Effluvium
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Novel drugs of United States Food and Drug Administration approved in 2024
- Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS)
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Research progress on mechanisms of skin aging and anti-aging strategies
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Establishing a robust preclinical model to investigate early and late radiation-induced skin reactions
- Therapeutic Potential of Nerve Growth Factor-Modified Hair Follicle Stem Cells Transplantation in a Rat Model of Alzheimer’s Disease
- What “regenerative” means in aesthetic medicine: a narrative literature review attempting to demystify the core essence of regenerative aesthetics
- Formulation and Evaluation of Herbal Anti-DandruffShampoo : A Comprehensive Review
- Trichoscopic Features, Clinical Correlates, and Risk Prediction in Female Pattern Hair Loss: A Retrospective Case-Control Study